EDP-235
EDP 235-001
Phase 1 small_molecule completed
Quick answer
EDP-235 for SARS CoV 2 Infection is a Phase 1 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- SARS CoV 2 Infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed